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Abstract
Objectives: Previous research identified alexithymia as a potential risk factor for substance use disorders (SUD). More insight into the
relation between alexithymia and SUD is needed in order to treat SUD effectively. Therefore, we investigated whether a familial vulnerability
to alcoholism relates to the presence and severity of alexithymia in SUD patients.
Method: Hospitalized, abstinent SUD-patients (n = 187), were assessed with the Toronto Alexithymia Scale (TAS-20) and Addiction
Severity Index (EuropASI). A maternal, paternal, and total continuous measure of the Family History of Alcohol (FHA) was developed.
Kruskal-Wallis tests and Spearman correlations were used to relate the composite scores of FHA to alexithymia as a categorical and
continuous measure. Multivariate regression models were performed to control for the effects of confounders on the relation between FHA
and alexithymia.
Results: Compared to moderate (33%) and low (17%) alexithymic SUD-patients, high alexithymic (50%) patients were more likely to have
fathers with alcohol problems (P = 0.004). Such a difference was not found for mothers with alcohol problems. The composite FHA-score
was significantly associated with alexithymia (Rs = .19, P = 0.01). However, only a paternal FHA, independent from disturbed family
functioning, related to the degree of alexithymia (β = .13, P = 0.06), especially to the Difficulty Identifying Feelings as measured by the
TAS-20 (β = .16, P = 0.02).
Conclusions: The relation between a paternal FHA and a higher degree of alexithymia in SUD-patients suggests that alexithymia could
mediate the familiality of alcoholism or SUD in the paternal line.
© 2013 Elsevier Inc. All rights reserved.
1. Introduction
Sifneos first described the notion of alexithymia in 1973
[1] as the inability to express emotions or feelings.
Alexithymia is mostly seen as a personality construct
characterized as a deficit in the ability to cognitively process
and regulate emotions [2]. Whereas the prevalence of
alexithymia in population-based studies varies between 8%
and 15% [3], rates of up to 67% have been reported in
patients with alcohol use disorders (AUD) [4] and up to 50%
in patients with other substance use disorders (SUD) [5,6]. In
socio-demographic studies, alexithymia has been associated
with older age, low educational level, low socio-economic
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status, poor perceived health, and depression, although not
all of these associations have been consistently observed in
all studies [7–9]. Additionally, in SUD, alexithymia was
related to state-anxiety and depression [10]. As alexithymia
has been described as a potential risk factor for SUD, and in
some studies, it has been related to negative treatment
outcomes, improving the understanding of the relation
between alexithymia and SUD could be of importance in
the treatment of SUD and the optimization of treatment
interventions [4,11,12].
In the context of further research into the relationship
between alexithymia and AUD, in particular in view of the
potential role of alexithymic traits in the etiology of AUD,
three previous studies looked at the effect of a family history
of alcoholism (FHA) on alexithymia [13–15]. One study
found strong alexithymic features in non-alcoholic sons with
an extensive generational paternal history of alcoholism, but
not in non-alcoholic sons without any family history or with
alcoholic fathers without an extensive family history [13]. In
the second study consisting of 100 male patients with alcohol
dependence, no relation between a FHA and alexithymia was
found [14]. However, both studies assessed alexithymia
using the Sifneos-Schalling Personality Scale (SSPS), which
lacks sufficient validity and internal reliability [2]. The most
recent study conducted with a non-clinical population found
an association between the Toronto Alexithymia Scale
(TAS-20) and being the offspring of an alcoholic parent, as
defined by the Children of Alcoholics Screening Test
(CAST) [15]. This population comprised 314 volunteers
(54% female and 53% university students) aged 18–
45 years, all of whom reported at least occasional alcohol
consumption and 6% using an illicit drug more than once per
month. Unfortunately, the results were limited in specificity
because the CAST does not allow differentiation between
mothers or fathers with alcohol problems.
A substantial genetic influence of alexithymia has been
demonstrated in a small and extensive twin pair study. This
was replicated in a study that controlled for depressive
symptoms [16–18]. Results from the first, small study [16]
indicated that familial influences contributed to all 3
subscales of the TAS-20, i.e. Difficulty Identifying Feelings
(DIF), Difficulty Describing Feelings (DDF) and Externally
Oriented Thinking (EOT). The results also suggested that
DIF and DDF were primarily influenced by nongenetic
shared family environmental factors and EOT by genetic
factors. However, because of the very small sample (77 twin
pairs) and the way of recruiting, the different results could be
due to selection bias [17]. Therefore the authors are not very
confident concerning the distribution of the genetic and
shared family environmental factors to the subscales of the
TAS-20 [16]. The two other larger studies (8,785 [17] and
729 [18] twin pairs) found no differences between the
subscales of the TAS-20. The Danish study [17] found
nonshared environmental effects of 50-56%, heritabilities of
30–33% and 12–20% of the variance of the alexithymia
scores being explained by shared environmental effects. In
the Italian study [18] nonshared environmental factors
accounted also for most of the variation in the TAS-20 and
its subscales. When corrected for depression and gender a
heritability factor of 33% was found for the total TAS-20,
with no significant differences between the subscales. No
significant contribution of shared environmental influences
on alexithymia was found [18].
Based on this genetic and familial influence, a higher
percentage of alexithymia is expected in parents and other
family members of alexithymic patients. As alexithymia and
alcohol use disorders are related, this could be a reason for
more alcohol problems in the relatives of alexithymic
patients [4,15]. However, in alexithymic patients with
SUD or AUD, other genetic, environmental or familial
mechanisms could of course have an important role in the
alcohol problems of their relatives [19].
As part of an often shared environmental or familial
mechanism, problems with alcohol in parents could result in
neglecting their child's emotional states, leading to emo-
tional self-regulation deficits, such as alexithymia. The latter
has been shown in a recent meta-analysis on parental
bonding and alexithymia [20]. A lack of maternal care, but
also maternal and paternal overprotection, related to
alexithymia [20]. In line with this, a disturbed family
functioning has been found to relate to the development of
alexithymic characteristics [21]. Similar finding was ob-
served for a history of neglect or sexual abuse, regardless of
whether it occurred within the family [22–24].
In this study, our aim was to test the hypothesis that the
presence of a FHA would be related to higher levels of
alexithymia in SUD-patients while controlling for disturbed
family functioning and other variables, representing a
combination of shared and unshared environmental issues.
2. Method
2.1. Subjects
Participants were SUD inpatients from three addiction
treatment centres in the East and South part of the
Netherlands. The study sample participated in a randomized
controlled trial investigating a Shared Decision Making
Intervention (SDMI) in addiction health care that was carried
out between January 2005 and December 2006 and published
in 2009 [25]. Overall, 187 of the 212 participants (88%) in the
RCT were willing to participate in the alexithymia study and
were assessed accordingly. No distinction was made for the
kind of substance(s) used. Exclusion criteria were being
younger than 18 years of age, insufficient knowledge of the
Dutch language, severe psychiatric co-morbidity precluding
their participation in the SDM-intervention, or no signed
informed consent. All patients have been diagnosed accord-
ing to DSM-IV-TR as having one or more substance related
disorders. The Dutch Ethical Assessment Committee for
Experimental Investigations on People (No. 4.108) approved
the study, and all participants gave written informed consent.
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2.2. Instruments
For the assessment of alexithymia, theDutch version of the
TAS-20 was used [26–28]. It comprises three factors, DIF,
DDF, and EOT. The TAS-20 demonstrated good internal
consistency (α = .81) and test-retest reliability over a three-
week interval (r = .77). The TAS-20 further has a three factor
structure congruent with the alexithymia construct [26,27].
Each item was measured on a five-point Likert scale ranging
from “completely disagree” to “completely agree”. We used
the total score and the 3 factor scores of the TAS-20 as
dependent measures. The TAS-20 total scores can be
categorized according to the empirically derived cut-off
points suggested by Taylor et al. [2]. A total score of 61 and
above indicates a high alexithymia score, scores between 52
and 60 represent a moderate degree, and scores of 51 and
below indicate a low alexithymia score. The internal
consistency of the total Dutch TAS-20, DIF, and DDF in
psychiatric outpatients and students varied between α = .67
and α = .85. The internal consistency of the EOT in general
population and psychiatric patient samples was lower
(α = .52–.66). The test-retest reliability in psychiatric out-
patients over a three-month interval was satisfactory for the
total TAS-20 (r = .74) and DIF-factor (r = .71) but was less so
for the DDF- (r = .68) and EOT-factors (r = .66) [28].
Type of substance use disorder was assessed by using the
Composite International Diagnostic Interview, Substance
Abuse Module (CIDI-SAM) [29]. The CIDI-SAM is an
expanded and more detailed version of the substance use
sections of the CIDI. The interview questions address the
diagnostic criteria of DSM-IV-TR and ICD-10 psychoac-
tive SUD.
Severity of substance use at baseline was measured using
the European Addiction Severity Index (EuropASI) [30,31].
The EuropASI is a clinical research interview designed to
assess problem severity in 7 areas of functioning: physical
health, employment, alcohol and/or drug use, legal, family/
social, and psychiatric. Seven severity domains with scores
that could range from 0 (no problem) to 9 (extremely serious
problem) were derived from this interview. The family/social
domain of the EuropASI represents an estimate of family and
social problems and includes items assessing patients'
history of trauma (physical or sexual). It is a combination
of shared and unshared environmental issues.
2.3. Data analysis
Because alexithymia is better conceptualized as a
continuous rather than a categorical variable [32], we
especially examined associations with alexithymia as a
continuous variable. However, to gain more insight on our
patient sample from a clinical point of view, we also
examined some associations with alexithymia as a categor-
ical variable with low, intermediate, and high levels. Chi-
Square tests were used to analyse dichotomous or categorical
data and ANOVA or the Kruskal-Wallis test were used to
analyse continuous data.
To assess the degree of FHA, we created a maternal,
paternal, and total FHA variable by multiplying 1st family
degree by a factor 3, 2nd degree by a factor 2, and 3rd degree
by a factor 1, and then adding these scores up to a total
maternal and paternal FHA-variable. We did use a
genealogical classification of the different degrees of family
relatedness: 1st family degree was represented by the
biological parents (score range: 0–2: 0 = no parent with
alcoholism; 1 = one parent with alcoholism etc.), 2nd degree
by grandparents (score range: 0–4), brothers and sisters
(score range; 0–4) and 3rd degree by aunts and uncles (score
range: 0–4), Other (biological) family members were not
assessed by the EuropASI and therefore not available. In
case of unfamiliarity or doubt about the FHA or absence of
specific family members, values were scored as negative for
alcoholism. To check the validity of these variables, we
related them to a well-known typology of alcohol depen-
dence, namely Early (EOA) (≤25 years) or Late Onset
Alcoholism (LOA) (N25 years) with more evidence of
familial alcoholism for EOA [33]. EOA or LOA was based
on the EuropASI-question that inquired about the age at
which patients started to drink 5 or more units of alcohol
per occasion.
Multivariate linear regression models were conducted
with total TAS-20 and factor scores as the dependent
variables. The predictor variables, mostly based on previous
research, were total, maternal and paternal FHA, age, gender,
and EuropASI “family/social relations” and “psychiatric”
domains [7,11,24,25]. Variables with a P b 0.2 in univariate
analyses were entered in a full multivariate model.
Subsequently, non-significant variables were removed, one
by one, until R-squared changed by more than 10%.
All statistical tests were 2-sided, considered significant at
a P value ≤ 0.05, and conducted using SPSS for Windows
(release 16.0).
3. Results
3.1. Patient characteristics
According to the cut-off score, 37% (n = 69) had a high
degree of alexithymia, 30% (n = 56) had a moderate degree
of alexithymia, and 33% (n = 62) had low alexithymia. The
mean TAS-20 score was 55.7 (SD = 11.3). Forty-seven
(25%) patients were female. Mean age was 40.7 years
(SD = 10.9) and 94% was born in the Netherlands.
Seventeen percent was married, 39% was divorced or
widowed, and 44% had never been married. Forty-four
percent was unemployed and mean years of education was
11.4 (SD = 3.0). Most, 54%, preferred alcohol as the
substance of preference, 29% polydrugs, 11% cocaine or
other stimulants, 4 % cannabis, and 2% other substances,
with no gender differences. Alexithymia was measured as a
continuous variable related to years of education (r = −.19,
P = 0.01) and the EuropASI “psychiatry” domain (r = .31,
P b 0.001), but unrelated to gender, age, country of birth,
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kind of relationship, degree of employment, years of alcohol
or drug use, type of substance dependence, substance
preference, and other EuropASI domains.
3.2. Relation between FHA and early (EOA) or late-onset
alcoholism (LOA)
No significant differences were found between the
maternal FHA in EOA (n = 82) [Mdn = 0.0 (IQR = 0.0–
2.2)] and in LOA (n = 53) [Mdn = 0.0 (IQR = 0.0–1.0)]
(U = 1845.0, z = −1.7, P = 0.09) and between the paternal
FHA (n = 82) in EOA [Mdn = 0.0 (IQR = 0.0–3.0)] and in
LOA (n = 53) [Mdn = 0.0 (IQR = 0.0–3.0)] U = 1969.5,
z = −1.0, P = 0.31). However, a difference was found
between EOA (n = 81) [Mdn = 3.0 (IQR = 0.0–6.0)] and
LOA (n = 53) [Mdn = 2.0 (IQR = 0.0–4.0)] (U = 1714.0,
z = −2.0, P = 0.05) for the total FHA-variable.
3.3. Relation between FHA and alexithymia
High alexithymic patients were more likely to have
alcoholic fathers but not mothers compared to moderate and
low alexithymic patients (Table 1). When comparing
patients with none, one, or two alcoholic parents, we found
that high alexithymic patients were more likely to have
two alcoholic parents compared to moderate and low
alexithymic patients. Looking at the paternal, maternal, and
total FHA, high alexithymic patients obtained higher scores
on the total, paternal, and maternal FHA compared to low
alexithymic patients.
Mean (SD) of the total TAS-20 for patients with non-
alcoholic mothers did not differ from the mean obtained
by patients with alcoholic mothers [M = 55.3 (11.4);
M = 58.1 (11.4); t (181) = 1.2, P = 0.23]. These patients
did not differ in the DIF [M = 18.8 (6.4); M = 20.9 (6.7);
t (181) = 1.6, P = 0.11], DDF [M = 16.3 (4.3); M = 16.4
(3.8); t (181) = 0.7, P = 0.91] and EOT [M = 20.3 (4.2);
M = 20.9 (4.1); t (181) = 0.7, P = 0.47]. However,
differences were found for patients with non-alcoholic
versus alcoholic fathers on the TAS-20 [M = 53.9 (11.7);
M = 59.1(9.8); t (177) = 3.0, P = 0.003], the DIF-factor
[M = 17.9 (6.5); M = 21.2 (5.5); t (177) = 3.3,P = 0.001] and
the DDF-factor [M = 15.8 (4.4); M = 17.1 (3.9); t (177) = 2.0,
P = 0.05], but not on the EOT-factor [M = 20.2 (4.1);
M = 20.8 (4.2); t (177) = 1.0, P = 0.32].
When comparing patients with none, one, or two alcoholic
parents, the total TAS-20 [M = 53.9 (12.0); M = 57.9 (9.3);
M = 60.1 (11.3); F (2, 173) = 3.5, P = 0.03] and the DIF-
factor [M = 18.0 (6.6); M = 20.1 (5.5); M = 22.3 (6.3); F (2,
173) = 4.5, P = 0.01] differed, but not the DDF and EOT-
factors. Post hoc tests (Tukey HSD) showed a significant
difference between patients with none and two alcoholic
parents in the DIF-factor only.
The results indicated significant correlations (Spearman)
between maternal FHA and both the total TAS-20 (Rs = .15,
P = 0.04; n = 187) and the DIF-factor (Rs = .20, P = 0.006;
n = 187), between paternal FHA and both the total TAS-20
(Rs = .19, P = 0.01; n = 187) and the DIF-factor (Rs = .24,
P = 0.001; n = 187), and between total FHA and both the
TAS-20 total (Rs = .19, P = 0.01; n = 186) and the DIF-
factor (Rs = .28, P b 0.001; n = 186).
3.4. Estimating the relation between the FHA and
alexithymia, controlling for gender, age, EuropASI
“family/social relations” and “psychiatry” domains
When performing multivariate regression models with
the total TAS-20 or TAS-20 factors as dependent variables,
total FHA contributed a small part (β(r) = .16, P = 0.02) to
the variance in the DIF-factor and although not signifi-
cantly (β(r) = .13, P = 0.11) to the variance in the total
TAS-20, next to the “psychiatry” domain of the EuropASI
and the years of education (Table 2). Regression models
conducted separately for the maternal and paternal line
indicated that only paternal FHA contributed a small part to
Table 1
Family history of alcoholism: characteristics of low, moderate and high alexithymic patients (n = 187).
Patient characteristics Low alexithymic
(TAS b 52)
Moderate alexithymic
(51 b TAS b 61)
High alexithymic
(TAS N 60)
χ2 H P
n = 62 (33.2%) n = 56 (29,4%) n = 69 (36.9%)
Mother %(n) 1.9 0.38
Alcoholic(−) 35.1(54) 29.2(45) 35.7(55)
Alcoholic(+) 24.1(7) 27.6(8) 48.3(14)
Father %(n) 11.1 0.004
Alcoholic(−) 41.3(50) 28.1(34) 30.6(37)
Alcoholic(+) 17.2(10) 32.8(19) 50.0(29)
Parents %(n) 12.2 0.02
Alcoholic(−) 41.8(46) 26.4(29) 31.8(35)
Alcoholic(+) 20.0(10) 38.0(19) 42.0(21)
Alcoholic(++) 18.8(3) 18.8(3) 62.5(10)
Maternal FHA Mdn(IQR) 0.0(0.0–0.0) 0.0(0.0–1.8) 0.0(0.0–3.0) 7.6 0.02
Paternal FHA Mdn(IQR) 0.0(0.0–1.0) 0.0(0.0–3.0) 0.0(0.0–3.0) 9.3 0.01
Total FHA Mdn(IQR) 1.0(0.0–4.0) 3.0(0.0–5.0) 3.0(0.5–6.0) 9.5 0.009
Notes: Mdn = Median, IQR = Interquartile Range: 25th–75th percentile; FHA = Family History for Alcoholism; H = Kruskal-Wallis test.
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the variance in the total TAS-20 (β(r) = .13, P = 0.06) and
the DIF-factor (β(r) = .16, P = 0.02) (Table 3).
4. Discussion
In response to our research question, we found that high
alexithymic SUD-patients were more likely to have fathers
or both fathers and mothers, but not mothers only, with
alcohol problems compared to low alexithymic SUD-
patients. Next, we found that especially paternal FHA
relates to the degree of alexithymia, independent of disturbed
family functioning.
The high degree of alexithymia in our abstinent SUD
sample is consistent with previous reports [4,10,34]. Higher
scores on the “psychiatry” severity EuropASI domain
reflect symptoms of anxiety and depression [31]. The
relationship between alexithymia and these symptoms
suggests that the high baseline alexithymia score can at
least partially be interpreted as a state phenomenon [4,34].
That relationship is also the reason why we controlled for
“psychiatry” severity while analysing the association
between alexithymia and FHA. Alexithymia was related
to years of education, as was found in previous studies of
the general population [3,8], but not in all [35]. Salminen
et al. [3] argued that alexithymic persons are less likely to
seek higher education reflecting the social status, values
and emotional atmosphere in the family of origin and
therefore yielding information about the individual’s
developmental background. In our study, years of educa-
tion were related to the EOT-factor and not to the DIF- and
DDF-factor. The aforementioned studies [3,8] did not
consider the relations between years of education and the
TAS-20 factors. Further developmental and longitudinal
studies of alexithymic persons are therefore needed to
address the relation between years of education and
alexithymia, in particular on factor level. However, we do
agree with Salminen et al. [3] that a higher education often
requires more psychological introspection and therefore
could be less attractive for alexithymic individuals.
The results indicated no significant differences between
patients with and without alcoholic mothers in total
alexithymia as a dimensional variable or factor scores. We
did find a relation between the maternal FHA and
alexithymia as a categorical and dimensional variable (total
TAS and DIF-factor). However, the effect sizes for
alexithymia as a continuous variable were small and the
relation disappeared when controlling for psychiatric
problems, including anxiety, depression, and the paternal
FHA. Therefore, no relation was found between mothers
with an alcohol problem themselves or their families and
alexithymia in their offspring.
For patients with alcoholic fathers, we found a higher
degree of total alexithymia, DIF-, and DDF-factors com-
pared with patients of non-alcoholic fathers, as supported by
differences among high, moderate, and low alexithymic
patients in percentage of alcoholic fathers. Although the
relation between the paternal FHA and offspring alexithymia
as a dimensional variable (total TAS and DIF-factor) had a
small effect size, it remained significant after controlling for
psychiatric problems and other possibly confounding factors
like gender, age, and problems in the family or social
relations. This indicates that a paternal FHA relates to
alexithymia in SUD-patients and is in line with the study of
Finn et al. [13], that demonstrated a relation between a
paternal FHA and alexithymia, but unlike the study of
Rybakowski et al. [14], in which no relation between FHA
and alexithymia was found. In both studies, the FHA was
defined as a categorical variable, unlike our continuous
score. Next, these studies used an insufficiently valid and
unreliable instrument, the SSPS, for assessing alexithymia
and did not account for possible confounders [2,13,14].
Because the SSPS has another factor structure that has not
been validated [2], unlike the TAS-20 [26,27], we could not
Table 2
Multivariate linear regression analyses predicting TAS-20 total and factors
from gender, age, the “family/social” and “psychiatry” domains and total
family history of alcoholism (FHA).
Β(r) P R2 Fchange P
TAS-20 total (n = 185) .14 9.39 b0.001
“Psychiatry” domain .28 b0.001
Years of education -.15 0.02
Total FHA .13 0.11
DIF-factor (n = 185) .22 24.93 b0.001
“Psychiatry” domain .40 b0.001
Total FHA .16 0.02
DDF-factor (n = 186) .05 9.22 0.003
“Psychiatry” domain .22 0.003
EOT-factor (n = 187) .09 8.70 b0.001
Gender −.15 0.03
Years of education −.26 b0.001
Non-significant variables were removed until R-squared changed by more
than 10%.
Table 3
Multivariate linear regression analyses predicting TAS-20 total and factors
from gender, age, the “family/social” and “psychiatry” domains and family
history of alcoholism (HFA) of the maternal and paternal lines.
Β(r) P R2 Fchange P
TAS-20 total (n = 186) .14 10.04 b0.001
“Psychiatry” domain .28 b0.001
Years of education −.16 0.06
Paternal FHA .13 0.06
DIF-factor (n = 186) .21 23.68 b0.001
“Psychiatry” domain .40 b0.001
Paternal FHA .16 0.02
DDF-factor (n = 186) .05 9.22 0.003
“Psychiatry” domain .22 0.003
EOT-factor (n = 187) .09 8.70 b0.001
Gender −.15 0.03
Years of education −.26 b0.001
Non-significant variables were removed until R-squared changed by more
than 10%.
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make a comparison on alexithymia factor levels between our
study and that of Finn et al. [13].
High alexithymic patients had a higher percentage of both
parents with alcohol problems compared to moderate and low
alexithymic patients. Further, patients who had both parents
with alcohol problems scored higher on the DIF-factor
compared to patients without alcohol abusing parents.
However, without controlling for unshared environmental
or psychological confounders, this is not a strong indication
for a familial component in the relation between alcohol
problems of the parents and a higher alexithymia score in
their offspring. For the total FHA, we controlled for some
shared (family domain of the EuropASI) and unshared (social
relation domain of the EuropASI, age and gender) environ-
mental and psychological confounders. We found that total
FHA explained a small part of the variance in the total
alexithymia and the DIF-factor. Because this part of the
explained variance was just as large as for the paternal FHA,
only the latter is of interest in explaining a part of the high
prevalence of alexithymia in SUD-patients. We have no good
explanation for only a paternal familial transmission. In
familial transmission and inheritance studies of alexithymia,
no gender differences were found [16–18]. Although some
evidence exist concerning sex differences in the inheritance
of alcoholism [36] most research suggests an equivalent
genetic load for alcohol dependence in both genders [37] and
the absence of gender difference in familial transference [38].
Our measure of FHA reflects a combination of genetic
and shared environmental aspects and it is impossible to
discern the genetic (including gene-environment interaction)
and the shared environmental part that contributed to the
variance of the DIF-factor and the total TAS-20. In previous
twin studies on alexithymia [16–18] no agreement was
found in the contribution of the genetic and shared
environmental parts on the subscales of the TAS-20. Without
one or more replications of our finding it therefore makes
little sense to look for explanations that only the DIF-factor
and not the DDF- and EOT-factor were related to the FHA.
Our results should be interpreted in the context of some
limitations. Our measures of depression, anxiety, and
family functioning, especially the relation between parents
and patients, were rather global and not specific enough to
distinguish unshared and shared environmental issues. We
constructed a new measure of total FHA, which was
related to an EOA. However, our measure of paternal FHA
was not, and familial alcoholism in EOA is especially seen
in the paternal line [33]. Finally, we used the family
history approach and collected information on family
members from our patients rather than from these family
members themselves.
In conclusion, we did find a relation between a paternal
FHA and a higher degree of alexithymia in SUD-patients,
with an indication that this relation is partly based on a
familial component. The clinical importance of this finding
is that alexithymia could mediate the familiality of
alcoholism or SUD in the paternal line, however, to a
small extent, given the correlations of the paternal FHA with
total TAS-20 (β(r) = .13) and DIF-factor (β(r) = .16). In
order to look for more causal models to explain this
relationship, structural equation modeling should be per-
formed on larger datasets of twins and extended family that
would provide both data on substance use and alexithymia of
all family members. Further, more directly, candidate genes
may be considered to test for associations between genetic
polymorphisms shown to be related to alexithymia and
alcoholism [39,40]. With more indications for alexithymia as
an endophenotype that mediates familial risk for alcoholism,
it would be interesting to develop evidence-based treatments
for alexithymia, which to our knowledge do not exist.
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